US Bancorp DE and Wells Fargo & Company MN have reportedly sold a significant number of Hologic, Inc. (HOLX) shares while Assetmark Inc., Corient Private Wealth LLC and PNC Financial Services Group Inc. have increased their holdings. Despite instances of price fluctuation and underperformance in comparison to market competitors, analysts hold a generally positive projection for HOLX's performance, contending it as a suitable selection for growth investors. Factors cited include robust sales in non-COVID diagnostics and Q1 earnings beating estimates. Other discussions encompass possible reduced optimism from company insiders selling company stock and a prediction of possible headwinds. There is notable interest in HOLX's international revenue trends, and a mention of a recall on a Hologic product due to injury risk. Amid this, Hologic continues to attract investor attention, with several earnings beats and growth forecasts anticipated. News about the company's continued focus on women's health and the election of new members to its Board of Directors provide insight into Hologic's strategic moves.
Hologic HOLX News Analytics from Fri, 09 Dec 2022 08:00:00 GMT to Thu, 30 May 2024 10:50:28 GMT -
Rating 2
- Innovation 5
- Information 6
- Rumor -2
